These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10863533)

  • 1. Oxidative stress, mitochondrial respiration, and Parkinson's disease.
    Cohen G
    Ann N Y Acad Sci; 2000; 899():112-20. PubMed ID: 10863533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkinson disease: a new link between monoamine oxidase and mitochondrial electron flow.
    Cohen G; Farooqui R; Kesler N
    Proc Natl Acad Sci U S A; 1997 May; 94(10):4890-4. PubMed ID: 9144160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of brain mitochondrial respiration by dopamine and its metabolites: implications for Parkinson's disease and catecholamine-associated diseases.
    Gluck MR; Zeevalk GD
    J Neurochem; 2004 Nov; 91(4):788-95. PubMed ID: 15525332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxic interactions between dopamine, α-synuclein, monoamine oxidase, and genes in mitochondria of Parkinson's disease.
    Naoi M; Maruyama W; Shamoto-Nagai M; Riederer P
    J Neural Transm (Vienna); 2024 Jun; 131(6):639-661. PubMed ID: 38196001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoxidation and MAO-mediated metabolism of dopamine as a potential cause of oxidative stress: role of ferrous and ferric ions.
    Hermida-Ameijeiras A; Méndez-Alvarez E; Sánchez-Iglesias S; Sanmartín-Suárez C; Soto-Otero R
    Neurochem Int; 2004 Jul; 45(1):103-16. PubMed ID: 15082228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel bifunctional drugs targeting monoamine oxidase inhibition and iron chelation as an approach to neuroprotection in Parkinson's disease and other neurodegenerative diseases.
    Youdim MB; Fridkin M; Zheng H
    J Neural Transm (Vienna); 2004 Oct; 111(10-11):1455-71. PubMed ID: 15480846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metabolism of tyramine by monoamine oxidase A/B causes oxidative damage to mitochondrial DNA.
    Hauptmann N; Grimsby J; Shih JC; Cadenas E
    Arch Biochem Biophys; 1996 Nov; 335(2):295-304. PubMed ID: 8914926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease.
    Berman SB; Hastings TG
    J Neurochem; 1999 Sep; 73(3):1127-37. PubMed ID: 10461904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile.
    Aubin N; Barneoud P; Carter C; Caille D; Sontag N; Marc C; Lolivier J; Gardes A; Perron C; Le Kim A; Charieras T; Pandini M; Burnier P; Puech F; Jegham S; George P; Scatton B; Curet O
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1171-82. PubMed ID: 15178694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine metabolism and neurotransmission in primate brain in relationship to monoamine oxidase A and B inhibition.
    Youdim MB; Riederer P
    J Neural Transm Gen Sect; 1993; 91(2-3):181-95. PubMed ID: 8390270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective inhibition of monoamine oxidase A or B reduces striatal oxidative stress in rats with partial depletion of the nigro-striatal dopaminergic pathway.
    Aluf Y; Vaya J; Khatib S; Loboda Y; Finberg JP
    Neuropharmacology; 2013 Feb; 65():48-57. PubMed ID: 22982254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ecstasy-induced oxidative stress to adolescent rat brain mitochondria in vivo: influence of monoamine oxidase type A.
    Alves E; Summavielle T; Alves CJ; Custódio JB; Fernandes E; de Lourdes Bastos M; Tavares MA; Carvalho F
    Addict Biol; 2009 Apr; 14(2):185-93. PubMed ID: 19076925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective and neurorestorative activities of a novel iron chelator-brain selective monoamine oxidase-A/monoamine oxidase-B inhibitor in animal models of Parkinson's disease and aging.
    Bar-Am O; Amit T; Kupershmidt L; Aluf Y; Mechlovich D; Kabha H; Danovitch L; Zurawski VR; Youdim MB; Weinreb O
    Neurobiol Aging; 2015 Mar; 36(3):1529-42. PubMed ID: 25499799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoamine oxidase inhibits mitochondrial respiration.
    Cohen G; Kesler N
    Ann N Y Acad Sci; 1999; 893():273-8. PubMed ID: 10672247
    [No Abstract]   [Full Text] [Related]  

  • 15. Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B.
    Youdim MB; Gross A; Finberg JP
    Br J Pharmacol; 2001 Jan; 132(2):500-6. PubMed ID: 11159700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoamine oxidase and α-synuclein as targets in Parkinson's disease therapy.
    Follmer C
    Expert Rev Neurother; 2014 Jun; 14(6):703-16. PubMed ID: 24852232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3,4-Dihydroxyphenylethanol (Hydroxytyrosol) Mitigates the Increase in Spontaneous Oxidation of Dopamine During Monoamine Oxidase Inhibition in PC12 Cells.
    Goldstein DS; Jinsmaa Y; Sullivan P; Holmes C; Kopin IJ; Sharabi Y
    Neurochem Res; 2016 Sep; 41(9):2173-8. PubMed ID: 27220335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of MAO-B and COMT: their effects on brain dopamine levels and uses in Parkinson's disease.
    Finberg JPM
    J Neural Transm (Vienna); 2019 Apr; 126(4):433-448. PubMed ID: 30386930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of brain mitochondrial respiration by dopamine: involvement of H(2)O(2) and hydroxyl radicals but not glutathione-protein-mixed disulfides.
    Gluck M; Ehrhart J; Jayatilleke E; Zeevalk GD
    J Neurochem; 2002 Jul; 82(1):66-74. PubMed ID: 12091466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of rat brain mitochondrial electron transport chain activity by dopamine oxidation products during extended in vitro incubation: implications for Parkinson's disease.
    Khan FH; Sen T; Maiti AK; Jana S; Chatterjee U; Chakrabarti S
    Biochim Biophys Acta; 2005 Jun; 1741(1-2):65-74. PubMed ID: 15925494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.